Home / Health / Cancer Patients Seek Ivermectin Amidst Doctor Warnings
Cancer Patients Seek Ivermectin Amidst Doctor Warnings
19 Jun
Summary
- Ivermectin prescriptions for cancer patients more than doubled in seven months.
- Study shows white, male cancer patients in the South most interested.
- FDA has not approved ivermectin for any cancer treatment.
Interest in ivermectin for cancer treatment has surged, with prescriptions for cancer patients more than doubling between January and July 2025. This trend is particularly pronounced among white, male patients in southern states. The rise in demand is partly attributed to viral interviews and celebrity endorsements promoting the drug as a cancer cure.
However, medical professionals caution against its use. The U.S. Food and Drug Administration (FDA) has not approved ivermectin for treating any form of cancer in humans or animals. Doctors emphasize that there is insufficient evidence from clinical trials to support its efficacy as a cancer therapy. Major risks associated with high doses include seizures, coma, and death, with even smaller doses potentially exacerbating chemotherapy side effects like nausea and vomiting.
Experts stress that anecdotal success stories may overlook the impact of concurrent, established treatments. They urge patients to engage in informed discussions with their doctors rather than pursuing unproven remedies. Despite the lack of scientific validation and significant risks, ivermectin remains available over-the-counter in several states.
